Mackenzie Financial’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,657
Closed -$209K 1624
2024
Q1
$209K Buy
16,657
+5,881
+55% +$76K ﹤0.01% 1330
2023
Q4
$165K Hold
10,776
﹤0.01% 1360
2023
Q3
$160K Buy
10,776
+387
+4% +$6.03K ﹤0.01% 1302
2023
Q2
$185K Hold
10,389
﹤0.01% 1347
2023
Q1
$185K Sell
10,389
-5,902
-36% -$110K ﹤0.01% 1356
2022
Q4
$319K Buy
+16,291
New +$330K ﹤0.01% 1075
2015
Q2
Sell
-25,600
Closed -$623K 848
2015
Q1
$623K Buy
25,600
+4,800
+23% +$108K ﹤0.01% 627
2014
Q4
$463K Buy
20,800
+1,500
+8% +$35.6K ﹤0.01% 645
2014
Q3
$488K Buy
+19,300
New +$534K ﹤0.01% 619

Other funds holding TBI

Mackenzie Financial's TBI Position: Q2 2024 in Review

Mackenzie Financial sold out of Trueblue (TBI) in Q2 2024, closing a stake of 16,657 shares — an estimated $209K sold.

Mackenzie Financial first reported a position in TBI in Q3 2014 and held it in 9 quarters. The position peaked at $623K in Q1 2015. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

  • Mackenzie Financial reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
  • Mackenzie Financial sold 16,657 Trueblue shares in Q2 2024, an estimated $209K.
  • Mackenzie Financial first reported a position in Trueblue in Q3 2014 and held it in 9 quarters.
  • Mackenzie Financial's Trueblue position peaked at $623K in Q1 2015.
  • 121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on Mackenzie Financial's 13F filing for Q2 2024, filed 14 Aug 2024.